The orthopedic world of tiny structures and joints presents unique challenges in diagnostic imaging. With traditional 1.5T scanning, spatial resolution, imaging speed, and signal-tonoise ratios have left orthopedists wanting more. A new study indicates the move to advanced 3T imaging might be ideal for orthopedics.
The orthopedic world of tiny structures and joints presents unique challenges in diagnostic imaging. With traditional 1.5T scanning, spatial resolution, imaging speed, and signal-tonoise ratios have left orthopedists wanting more. A new study indicates the move to advanced 3T imaging might be ideal for orthopedics.
The study, published in the September issue of the Journal of Hand Surgery, found greater sensitivity, specificity, and accuracy in identifying a specific joint tear with MR scans at 3T than at 1.5T. Radiologist Dr. Meredith Amderson and colleagues at Mayo Clinic in Rochester, MN, compiled diagnostic MRIs of 102 patients presenting with ulnar-sided wrist pain over the last decade. The radiologists identified a tear of the triangular fibrocartilage complex, a small segment of cartilage in the wrist joint, in the majority of cases, but with greater detail at 3T than at 1.5T imaging.
"We can hopefully prevent the unnecessary use of diagnostic arthroscopy," Amderson said. "Reducing the risks of needless surgery can make a huge difference in orthopedic patient care."
-By Amy Lillard
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.